RVP

Retractable Technologies, Inc. is engaged in the manufacturing and marketing of safety medical products (predominately syringes) for the healthcare industry. The Company is focused on the production of injection devices (syringes and needles). Such products are marketed under the VanishPoint, Patient Safe, and EasyPoint brands. The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe syringes are designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections. The EasyPoint needle can also be used to aspirate fluids and for blood collection. Its products are distributed by various specialty and general line distributors.

Wall Street analysts forecast RVP stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for RVP is  USD with a low forecast of USD and a high forecast of USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

Retractable Technologies Inc revenue for the last quarter amounts to 10.09M USD, decreased -2.52 % YoY.

Retractable Technologies Inc. EPS for the last quarter amounts to 0.01 USD, decreased -114.29 % YoY.

Retractable Technologies Inc (RVP) has 221 emplpoyees as of December 16 2025.

Today RVP has the market capitalization of 24.98M USD.